Understanding kidney disease in sickle cell disorders

Molecular and Cellular Pathogenesis of Kidney Disease in Sickle Cell Disorders

NIH-funded research University of Pittsburgh at Pittsburgh · NIH-10749914

This study is looking at how kidney problems can happen in people with sickle cell disorders, especially focusing on how the breakdown of red blood cells might harm the kidneys, with the goal of finding new ways to protect kidney health for these patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh NIH-funded
Lab location1 site (Pittsburgh, United States)
Project IDNIH-10749914 on NIH RePORTER

What this research studies

This research investigates how kidney diseases, such as acute kidney injury and chronic kidney disease, develop in patients with sickle cell disorders. It focuses on the role of hemolysis, where red blood cells break down, releasing harmful substances that can damage the kidneys. By studying the mechanisms behind this process, the research aims to identify potential therapeutic targets to prevent kidney injury in these patients. The approach includes analyzing the levels of specific proteins in the blood and their effects on kidney cells.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with sickle cell disease, particularly those who have experienced kidney-related complications.

Not a fit: Patients without sickle cell disease or those who do not have kidney complications may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that protect the kidneys of patients with sickle cell disorders.

How similar studies have performed: Previous research has shown promising results in understanding kidney complications in sickle cell disease, but this specific approach is relatively novel.

Where this research is happening

Pittsburgh, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Hb SS diseaseHbSS diseaseHemoglobin S DiseaseHemoglobin sickle cell diseaseHemoglobin sickle cell disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.